Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

TC10 Activators

TC10 Activators encompass a diverse group of chemicals that can influence the activity of the RHOQ protein, either directly or through indirect modulation of associated signaling pathways. These activators, while not exclusively targeting RHOQ, play a pivotal role in the intricate network of cellular signaling, often affecting multiple Rho GTPases and their downstream effectors.

Among the notable activators, EGF (Epidermal Growth Factor) and Lysophosphatidic acid (LPA) are prominent. EGF, upon binding to its receptor EGFR, can activate various Rho GTPases, thereby influencing RHOQ. LPA, on the other hand, is recognized for its ability to activate several members of the Rho family GTPases, suggesting a possible indirect effect on RHOQ activity. Calpeptin, a calpain inhibitor, and Y-27632, a ROCK inhibitor are chemicals that can influence the downstream signaling of Rho GTPases, offering another avenue through which RHOQ can be modulated. Additionally, compounds like NSC23766 and ML141, which target Rac1 and Cdc42 respectively, might modulate RHOQ through shared or interconnected pathways. The cellular cytoskeleton, particularly actin dynamics, plays a crucial role in Rho GTPase signaling. Chemicals like Latrunculin A, which disrupts actin polymerization, and Jasplakinolide, which stabilizes actin filaments, can thereby influence the signaling pathways in which RHOQ is involved.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

LPA is known to activate several Rho family GTPases, which may indirectly affect RHOQ activity.

Calpeptin

117591-20-5sc-202516
sc-202516A
10 mg
50 mg
$121.00
$456.00
28
(1)

As a calpain inhibitor, it can potentially influence Rho GTPase signaling, including RHOQ.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

ROCK inhibitor that can influence downstream Rho GTPase signaling, potentially affecting RHOQ.

NSC 23766

733767-34-5sc-204823
sc-204823A
10 mg
50 mg
$151.00
$609.00
75
(4)

Targets Rac1 and can indirectly influence other Rho GTPases like RHOQ.

ML 141

71203-35-5sc-362768
sc-362768A
5 mg
25 mg
$137.00
$512.00
7
(1)

Cdc42 inhibitor that might indirectly modulate RHOQ through shared pathways.

Latrunculin A, Latrunculia magnifica

76343-93-6sc-202691
sc-202691B
100 µg
500 µg
$265.00
$815.00
36
(2)

Disrupts actin polymerization, potentially influencing Rho GTPase signaling, including RHOQ.

Jasplakinolide

102396-24-7sc-202191
sc-202191A
50 µg
100 µg
$184.00
$305.00
59
(1)

Stabilizes actin filaments, potentially affecting Rho GTPase signaling pathways.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Elevates cAMP levels which can influence Rho GTPase signaling, potentially affecting RHOQ.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

Another MEK inhibitor that might indirectly modulate RHOQ through MAPK/ERK pathway.

IPA 3

42521-82-4sc-204016
sc-204016A
5 mg
50 mg
$94.00
$458.00
6
(1)

PAK1 inhibitor that can influence Rho GTPase signaling, potentially affecting RHOQ.